Animal Health
Vetmedica - a provider of solutions for animal health
Expanded product line! Click here for more details
The veterinary medical arm of Boehringer Ingelheim (Canada) Ltd./Ltée, Vetmedica Division prides itself on being a provider of solutions that reduce disease in Canadian livestock and improving the health and quality of life for companion animals.
With innovative biological and specialty pharmaceutical products, direct links to a renowned global research and development team, and industry-leading technical service veterinarians, Vetmedica is focused on serving the needs of Canadian veterinarians and their animal patients.
Known innovators and industry experts
In this highly competitive industry, companies that stay ahead of the curve and work in partnership with all intersecting partners, are the ones that remain in the foreground. Boehringer Ingelheim is one of those companies.
Boehringer Ingelheim (Canada) Ltd./Ltée works with advanced products, not only to reduce disease and encourage wellness in animals, but also to build the reputation and enhance the quality of care delivered by our veterinary customers, hence increasing their profitability.
As known leaders and
innovators in this field, Boehringer Ingelheim (Canada) Ltd./Ltée
is frequently consulted for assistance in identifying new diseases and
formulating new therapies or new diagnostic techniques to control disease.
On the leading edge of Canadian animal health:
Metacam®
is the #1 NSAID for pain management and inflammation in Canada and the
first Boehringer Ingelheim Animal Health brand to break the USD 100
million net sales barrier globally.
Vetmedin®
is the fastest growing treatment for congestive heart failure in
dogs - proven to increase both quality and length of life - achieved
worldwide market leader status in 2008.
Boehringer Ingelheim helped release the QUEST study, which is the
largest canine heart health survey ever conducted.
In November 2006, launched
Ingelvac CircoFLEX®, an innovative ONE dose vaccine against porcine
circovirus (PCV2), that causes immune deficiency.
More than 130 million doses sold globally.
Introduced Ingelvac CircoFLEX-MycoFLEX®
combo to protect pigs against both PCV2 and Mycoplasma
hyopneumoniae with only ONE vaccine. Easy on the producer
and the pig!
Our Enterisol Ileitis vaccine against Lawsonia is administered via
water. This unique product is available as a frozen or
nonfrozen form.
Our Swine portfolio includes 3 PRRS vaccines: PRRS
MLV, PRRS ATP and ReproCyc PRRS-PLE to help you win the battle.
Boehringer Ingelheim's Express®
vaccine line represents the culmination of over two decades of
research, including numerous Canadian field-based, real-world
challenge studies. The Express® line contains BVD Types 1 and 2
along with the industry's strongest fetal protection label
claim.
Express®
is the first vaccine for cattle to come with a written guarantee
and remains the only vaccine offering a guarantee in conjunction
with the national animal traceability program (CCIA).
Bio-MycinTM
200 is an injectable antibiotic with very low reactivity and
remains one of the best-known brands in Canada.
Calvenza®
is an equine influenza and herpes virus combination vaccine that
contains the most current equine influenza strain on the market.
It is the first and only equine respiratory vaccine in Canada to
come with a written guarantee against equine influenza.
Ventipulmin®
is the only bronchodilator approved for use in horses in
Canada, for the treatment of acute and chronic airway diseases.
Sputolysin®,
a product used to soften and remove respiratory mucus,
complements the use of Ventipulmin®.
